Abstract

A patient hydration method includes administering hydration fluid to a patient, and a hydration fluid measurement device responsible to a source of hydration fluid, a patient urine output measurement device. A controller is responsive to the hydration fluid measurement device and the patient urine output measurement device. The controller operates the infusion device, in response …

Legal parties

Party
Inventors (applicants): Mark Gelfand, Howard R. Levin
Assignees (initial): PLC Medical Systems, Inc. (Milford, US)
Agents: Landiorio Teska & Coleman LLP (attorney)

The application was examined by Kevin C Sirmons (USPTO dept. 3767), Bradley Osinski

Claims

  • 1. A method comprising: …
  • 2. The method of claim 1 in which automatically infusing includes balancing the fluid infused …
  • 3. The method of claim 2 in which balancing occurs every 15 minutes or less …

Cited documents

Patents

  • Paz et al. US 6640649 B1, Nov. 1, 2003
  • Han et al. US 5891051 A, Apr. 1, 1999
  • Shock et al. US 2002/0072647 A1, Jun. 1, 2002
  • Kolberg US 4132644 A, Jan. 1, 1979
  • Gille et al. US 4712567 A, Dec. 1, 1987
  • Citrebaum et al. US 2003/0048185 A1, Mar. 1, 2003
  • Matsuda US 2002/0025597 A1, Feb. 1, 2002
  • Gelfand et al. US 7938817 B2, May. 1, 2011
  • Hilblom US 3954010 A, May. 1, 1976
  • Gelfand et al. US 7758562 B2, Jul. 1, 2010
  • Ireland et al. US 7278983 B2, Oct. 1, 2007
  • Ericson et al. US 7044002 B2, May. 1, 2006
  • Motegi et al. US 5981051 A, Nov. 1, 1999
  • Rudko et al. US 2008/0171966 A1, Jul. 1, 2008
  • Schael US 4275726 A, Jun. 1, 1981
  • Hiller et al. US 2003/0114786 A1 / 604/27, Jun. 1, 2003
  • Wiest et al. US 5176148 A, Jan. 1, 1993
  • Barbut US 6231551 B1, May. 1, 2001
  • Gelfand et al. US 2004/0167415 A1, Aug. 1, 2004
  • WO WO 97/16220, May. 1, 1997
  • Gelfand et al. US 2006/0253064 A1, Nov. 1, 2006
  • Rudko et al. US 2008/0027409 A1, Jan. 1, 2008
  • WO WO 99/06087, Feb. 1, 1999
  • Ireland et al. US 2004/0167464 A1, Aug. 1, 2004
  • Crozafon et al. US 6272930 B1, Aug. 1, 2001
  • Gelfand et al. US 2006/0052764 A1, Mar. 1, 2006
  • Buck et al. US 4728433 A, Mar. 1, 1988
  • Cartledge et al. US 6554791 B1, Apr. 1, 2003
  • Weickhardt US 4204957 A, May. 1, 1980
  • Levin et al. US 2007/0088333 A1, Apr. 1, 2007
  • Cartledge et al. US 6942637 B2, Sep. 1, 2005
  • Blankenship et al. US 4658834 A, Apr. 1, 1987
  • Ericson et al. US 2004/0025597 A1, Feb. 1, 2004
  • Zaitsu et al. US 2004/0193328 A1, Sep. 1, 2004
  • Flaherty US 7137964 B2, Nov. 1, 2006
  • McGrath et al. US 4216462 A, Aug. 1, 1980
  • Corbitt et al. US 4449538 A, May. 1, 1984
  • Rhea, Jr. US 5916153 A, Jun. 1, 1999
  • Ware et al. US 2005/0085760 A1, Apr. 1, 2005
  • Eshel et al. US 5916195 A, Jun. 1, 1999
  • Bullister et al. US 6171253 B1, Jan. 1, 2001
  • EP 0258690, Mar. 1, 1988
  • Hickle US 2004/0133187 A1, Jul. 1, 2004
  • Parrish US 4448207 A, May. 1, 1984
  • Paukovits et al. US 6537244 B2, Mar. 1, 2003
  • Savitz et al. US 4229299 A, Oct. 1, 1980
  • Orkin et al. US 5207642 A, May. 1, 1993
  • Jeng et al. US 2003/0048432 A1, Mar. 1, 2003
  • Hussein US 2002/0107536 A1, Aug. 1, 2002
  • Reid US 2004/0081585 A1, Apr. 1, 2004
  • Gelfand et al. US 2006/0235353 A1, Oct. 1, 2006
  • Arieff et al. US 6010454 A, Jan. 1, 2000
  • Jeppsson et al. US 5722947 A, Mar. 1, 1998
  • Vasko US 2005/0027254 A1, Feb. 1, 2005
  • Wheatman US 5814009 A, Sep. 1, 1998
  • Flaherty US 2004/0087894 A1, May. 1, 2004
  • Gelfand et al. US 2006/0270971 A1, Nov. 1, 2006
  • Cioanta et al. US 6796960 B2, Sep. 1, 2004
  • Ware et al. US 7029456 B2, Apr. 1, 2006
  • Perez US 4261360 A, Apr. 1, 1981
  • Da Silva et al. US 2008/0221512 A1, Sep. 1, 2008
  • Paukovits et al. US 6752779 B2, Jun. 1, 2004
  • Gelfand et al. US 2004/0163655 A1, Aug. 1, 2004
  • Talbot et al. US 2005/0065464 A1, Mar. 1, 2005
  • Levin et al. US 6514226 B1, Feb. 1, 2003
  • Fecondini US 4994026 A, Feb. 1, 1991
  • Levin et al. US 6531551 B2, Mar. 1, 2003
  • Starkweather et al. US 6740072 B2, May. 1, 2004
  • Cartledge et al. US 2004/0059295 A1, Mar. 1, 2004
  • Anderson, Jr. et al. US 4813925 A, Mar. 1, 1989
  • Jespersen US 4343316 A, Aug. 1, 1982
  • Westphal et al. US 5769087 A, Jun. 1, 1998
  • Conway et al. US 5098379 A, Mar. 1, 1992
  • Gelfand et al. US 8007460 B2, Aug. 1, 2011
  • Harvie US 2004/0243075 A1, Dec. 1, 2004
  • Utterberg US 2002/0151834 A1, Oct. 1, 2002
  • Gelfand et al. US 2010/0280445 A1, Nov. 1, 2010
  • Sarajarvi US 2002/0161314 A1, Oct. 1, 2002
  • Bowman et al. US 4291692 A, Sep. 1, 1981
  • Ellinwood, Jr. US 4146029 A, Mar. 1, 1979
  • Lebel et al. US 6827702 B2, Dec. 1, 2004
  • WO WO 2006/041496 A1, Apr. 1, 2006
  • Steuer et al. US 4504263 A, Mar. 1, 1985
  • Gelfand et al. US 2010/0204677 A1, Aug. 1, 2010
  • Ware et al. US 2006/0184084 A1, Aug. 1, 2006
  • Shahmirian et al. US 2004/0122353 A1, Jun. 1, 2004
  • Bollish et al. US 2006/0064053 A1, Mar. 1, 2006
  • Truitt et al. US 5910252 A, Jun. 1, 1999
  • Christensen et al. US 2004/0176703 A1, Sep. 1, 2004
  • Gelfand et al. US 2008/0033394 A1, Feb. 1, 2008
  • Schal US 4923598 A, May. 1, 1990

Brief Description of the Several Views of the Drawings

Other objects, features and advantages will occur to those skilled in the art from the following description of a preferred embodiment and the accompanying drawings, in which: FIG. 1 is a schematic …

Description

Field of the Invention

This invention relates to a patient hydration system and method wherein the rate of hydration fluid delivered to the patient is automatically adjusted based on the urine output of the patient …

Related Applications

This application is a divisional application of U.S. patent application Ser. No. 12/800,673 filed May 20, 2010, which is a continuation application of U.S. patent application Ser. No. 11/408,851, now U.S. …

Detailed Description of the Invention

Aside from the preferred embodiment or embodiments disclosed below, this invention is capable of other embodiments and of being practiced or being carried out in various ways. Thus, it is to be understood …

More details about Patient Hydration Method

Miscellaneous patent data

The exemplary claims include number 1, the recorded applicant's name is Gelfand Mark, the applicant's location - New York, NY, 21 figures depict the invention details, originally classified under Therapeutic material introduced or removed in response to a sensed body condition, the recorded inventor's name is Mark Gelfand, the inventor's state is NY, city - New York, the invention description is illustrated by 15 drawings, the application was examined by Kevin C Sirmons, the assistant Bradley Osinski (3767 USPTO department), the invention is named Patient Hydration Method, located in Milford (US), the assignee company is PLC Medical Systems, Inc., similar classification categories are having means for varying, regulating, indicating or limiting injection pressure, having more than one chamber, operated by the vapour pressure of the liquid to be sprayed or atomised, Therapeutic material introduced or removed in response to a sensed body condition, Devices to humidify the respiration air, Foldable, Nozzle insertable into body orifice, Port having resealable septum, Having deodorant means, Blood pumps, Artificial hearts, Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps, the grant number is 08444623 (publication number), the exemplary patent drawings are Schematic view of another embodiment, Schematic view of one embodiment, Patient Hydration Method, Schematic view of an example, numbered 13/134,398 (application), developed by Howard R. Levin et al., the patent was granted on May. 21, 2013, the agent - Landiorio Teska & Coleman LLP, the assignee is categorized as a United States company, claims 1-11 comprise the invention scope, the application publication date is Jun. 6, 2011, the term of the patent was extended by 205 days.

Invention classification information

The invention is classified under Therapeutic material introduced or removed in response to a sensed body condition, Devices for introducing or retaining media, e.g. remedies, in cavities of the body. The designated search classifications include Method.

Patent details
Publication number 08444623
Publication date May. 21, 2013
Kind code B2
Application number 13/134,398
Application date Jun. 6, 2011
Application type U
Application series code 13
Extension term 205
National classification 604/503
Total number of claims 11
Exemplary claims 1
Number of drawings 15
Number of figures 21
Quick navigation
More similar inventions

Cellulosic Fiber Compositions Having Odor Control and Methods of Making and Using the Same (US08809616, Aug. 19, 2014 / 12/154,653, May 23, 2008, Containing inhibitor to ammonia or bacteria formation), Gopal C. Goyal et al. / International Paper Company (Memphis, US)

Endovascular Device Tip Assembly Incorporating a Marker Device and Method for Making the Same (US08585680, Nov. 19, 2013 / 11/787,626, April 17, 2007, Including radiopaque or electromagnetic marker), Jeffry S. Melsheimer et al. / Cook Medical Technologies LLC (Bloomington, US)

Wound Sealing Fluid Delivery Apparatus and Method (US08506525, Aug. 13, 2013 / 12/927,369, Nov. 12, 2010, Means forceably introducing or removing material from body orifice or wound), Patrick L. Bosarge / University of South Alabama (Mobile, US)

Also viewed with this patent

Needle Assembly and Components Thereof (US08460249, June 11, 2013 / 13/604,089, Sept. 5, 2012, Cover or protector for body entering conduit movable axially relative to one another), Kevin Woehr / B. Braun Melsungen AG (Melsungen, DE)

Transdermal Systems for the Delivery of Therapeutic Agents Including Granisetron Using Iontophoresis (US08463373, June 11, 2013 / 12/955,043, Nov. 29, 2010, Infrared, visible light, ultraviolet, X-ray or electrical energy applied to body), Russell L. Morris et al. / Teikoku Pharma USA, Inc. (San Jose, US)

Systems, Devices, and Methods Including Catheters Having Components That Are Actively Controllable Between Transmissive and Reflective States (US08460229, June 11, 2013 / 12/927,297, Nov. 10, 2010, Devices Transferring Fluids From Within One Area of Body to Another), Victoria Y. H. Wood et al.

New documents
  • Process for the Production of the Actinobacillus Pleuropneumoniae Toxins APXI or APXIII in a Liquid Culture Medium Under Supply of Air Enriched in Carbon Dioxide
  • Method for Manufacturing Nonvolatile Memory Device
  • Supply Chain Demand Satisfaction
  • Supply-Line Management Device
  • Storage Control Device and Method for Managing Snapshot